Vitamin D Receptors

(R)-Acenocoumarol is a vitamin K epoxide reductase inhibitor, serving as a potent orally active anticoagulant. It exhibits superior in vivo anticoagulant potency compared to Warfarin, attributed to its longer plasma elimination half-life and slower plasma clearance rate. This compound is particularly valuable in research applications focused on coagulation studies and the pharmacodynamics of anticoagulants. Its unique chiral center allows for exploration into the distinct biological activities of its enantiomeric forms.

Pefcalcitol, a phosphodiesterase inhibitor, exhibits potential as a therapeutic agent for psoriasis management. Its unique 16-en-22-oxa-vitamin D3 structure contributes to its biological activity, influencing cellular signaling pathways associated with skin inflammation and proliferation. This reagent is instrumental in pharmacological research aimed at understanding psoriasis pathophysiology and developing innovative treatment strategies.

Metabolite of vitamin D2